$ESTA

JW Asset Management, LLC sold $4.7M of ESTA (indirect holdings)

JW Asset Management, LLC sold 65,100 indirectly-held shares of ESTABLISHMENT LABS HOLDINGS INC. (ESTA) at $72.89 ($4.75M total) on 2026-05-28.

Original reporting
SEC EDGAR · JW Asset Management, LLC
Published May 29, 2026, 12:49 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 8:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ESTA
Neutral
medium confidence
Mentioned
$ESTA
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ESTANeutralLow
01

Why it matters

The disclosed sale reduces the reporting party’s holdings to 2,890,582 shares after selling 65,100 shares at $72.89/share; absent other news, the market impact is likely sentiment-driven rather than fundamental.

02

Market read

Traders may monitor for follow-on filings (additional sales or buys) and compare with broader tape/volume, but this alone is not a new fundamental catalyst.

03

What to watch

No 10b5-1 plan is cited, but the filing still lacks context on motivations, timing constraints, or whether other holders are accumulating.

Relevance 6/10Novelty 6/10Timing: today/after-hours context from a Form 4 filed 2026-05-28

Background

The article is an SEC EDGAR Form 4 disclosure: JW Asset Management, LLC reported an open-market sale of ESTA shares.

Company-level read

Ticker impact

$ESTANeutralMedium confidence
Context

JW Asset Management sold 65,100 shares of Establishment Labs Holdings in an open-market transaction disclosed on SEC Form 4.

Expected impact

Low likelihood of a sustained price move solely from this Form 4 sale; any impact is likely short-lived.

Evidence & confidence

The filing is an ownership-reduction disclosure (indirect, open-market) with no 10b5-1 plan stated and no accompanying operational or financial news.

Market effects

Limited sector read-through; this is company-specific ownership activity without sector-wide signal.

None indicated.

None indicated.

Counterpoint

Open-market sales by funds/affiliates often reflect diversification or liquidity needs and may not signal reduced confidence in the business.

Key entities

  • ESTABLISHMENT LABS HOLDINGS INC.

    Subject of the SEC Form 4 insider transaction disclosure (ESTA).

  • JW Asset Management, LLC

    Reported an open-market sale of 65,100 shares of ESTA.

Related articles

$ESTAMed

Establishment Labs Q2 Earnings Call Highlights

Establishment Labs (NASDAQ:ESTA) reported Q2 updates on its Motiva breast implant business. Outside the U.S. revenue rose 4.4% to $42.8M, with Europe up 16%. Its Minimally Invasive platform generated $12.1M revenue, nearing 15% of full-year global revenue. Gross margin improved to 70.6%. Cash was $71.2M. FDA site audits began for U.S. reconstruction; no material revenue expected until 2027.

$ESTAMed

ESTABLISHMENT LABS HOLDINGS INC. (ESTA): Results of Operations and Financial Condition

ESTABLISHMENT LABS HOLDINGS INC. (ESTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 estaerq22026-ex991.htm EX-99.1 Document EXHIBIT 99.1 PRESS RELEASE Investor/Media Contact: Malavika William mwilliam@establishmentlabs.com Establishment Labs ® Reports Second Quarter 2026 Financial Results NEW YORK, NY, August 6, 2026 -- Establishment Labs Holdings Inc.